Welcome to the LatAm-EAS webinar series! This series serves as a dynamic platform bridging insights and discussions between Latin America region and our society’s experts. With a focus on fostering collaboration, understanding, and innovation, our series offers a diverse range of topics explored through four engaging webinars, each presented in both English and Spanish.
#4 How to improve the quality of care for patients with dyslipidemia?
December 11, 2024 at 20:00 CET
Language: English and Spanish
Long-term adherence to lipid-lowering therapy poses one of the greatest challenges in cardiovascular prevention. The effectiveness of therapy heavily depends on the individualization of medical treatment, the identification and resolution of barriers that prevent full treatment adoption, and the implementation of best practices in medical services. Cultural issues and peculiarities of care delivery systems hinder the universal application of the same strategies.
This symposium will feature a review of the variability in the effectiveness of lipid-lowering therapy around the world. Additionally, examples of best practices implemented in Europe and Latin America will be described. All presentations will be given by highly recognized leaders in the field, representing the European Atherosclerosis Society and the EAS LATAM group.
Register hereAgenda:
20:00 Introduction to the webinar
20:05 Effectiveness of lipid-lowering therapies around the world. Kausik K. Ray
20:30 Actions to improve the quality of care for patients with dyslipidemia: The Case for Europe. Alexandros Tselepis
20:50 Actions to improve the quality of care for patients with dyslipidemia: The Case for Latin America. Andrei Sposito
21:10 Discussion and Q&A
Chair:
Carlos A. Aguilar Salinas
Founder of the Lipid Clinic and the current Head of Nutrition at the Instituto Nacional de Ciencias Medicas y Nutricion (INCMNSZ), Mexico City
Speakers:
Kausik K. Ray
Professor, BSc(hons), MBChB, MD, MPhil (Cantab), FRCP (Lon), FRCP (Ed), FACC, FESC, FAHA
Professor of Public Health at the School of Public Health, the Director of the Imperial Centre for Cardiovascular Disease Prevention and the Deputy Director of the Imperial Clinical Trial Unit, Imperial College London and a Consultant Cardiologist.
Alexandros Tselepis
Professor of Biochemistry-Clinical Chemistry University of Ioannina, Greece
Director of the Atherothrombosis Research Centre of the University of Ioannina, Greece
Andrei Sposito
MD, PhD, Director of Atherosclerosis and Vascular Biology Lab na FCM – UNICAMP, Universidade Estadual de Campinas